Four endpoints, including logP, Protein Adsorption, ROS in A549 cells, and Zeta Potential in Water are used to evaluate the bioactivities and toxicities of Platinum Nanoparticles (PtNPs). The pre-developed models of NanoAID-9, NanoAID-12, NanoAID-15, and NanoAID-16 are used to predict these four endpoints for the library nanomaterials, respectively.
For additional details on the four endpoints, refer to NanoAID-9, NanoAID-12, NanoAID-15, and NanoAID-16 on the Assay page.